
ExoCARES: Getting access to resources you need in the prostate cancer journey
ExoCARES (Comprehensive Assistance and Resources from Exosome Support) helps you navigate the prostate cancer journey with clarity and confidence.
The ExoDx Prostate test, or “EPI,” is a simple, non-invasive urine test that can help you and your doctor determine the need for a prostate biopsy. The ExoDx Prostate test provides actionable information that aids the prostate biopsy decision for men in the PSA ‘gray zone’ of 2-10ng/mL, and is not dependent on PSA or other clinical risk factors.
Clarity and confidence, we've got you covered.
Focus on keeping healthy and let us worry about the rest. Exosome Diagnostics is committed to communicating out of pocket costs to patients
so there is no surprise billing.
Depending on your specific circumstances, trained professionals at Exosome Diagnostics can help you with your journey to ensure the ExoDx Prostate test is:
- Covered by your insurance when possible
- Covered by a VA Medical Center and the Government Services Award if applicable
- Covered by the ExoCARES (Comprehensive Assistance and Resources from Exosome Support) Program, which provides personalized payment options
- Supported each step along your journey by the Patient Advocacy Team

The Insurance Process by ExoCARES
- Submit a claim
A claim is submitted to your insurer. - Receive an EOB
Receive an Explanation of Benefits (EOB) from our insurer. This is not a bill. - Payment covered by your insurance
In many cases insurance will pay for the complete cost of your test. - ExoCARES coverage & appeal
In the event your insurance company does not pay, we may appeal on your behalf. - Personalized consultation
If, after appeal, there is no insurance coverage, an ExoCARES Representative will contact you to review options. One call will be made, please call back.
Covered by Medicare
Traditional Medicare
covers the ExoDx Prostate
test for most patients in the
intended use population.
Most Medicare Advantage
plans cover The ExoDx
Prostate test.
Supported by Guidelines
The ExoDx Prostate test
is included in the NCCN
guidelines and covered
by major insurance plans
throughout the US. It is
also covered through all
VA Medical Centers.
Covered by the Patient Advocacy Team
For patients whose insurance
does not cover the ExoDx
Prostate test, our Patient
Advocacy Team will auto-enroll
you in The ExoCARES Program
which will provide services that
may reduce out-of-pocket costs.
What exactly is PSA?
Prostate-specific antigen, or “PSA,” is a routine blood test measured for many men in the primary care or urology setting. While PSA levels are not prostate cancer-specific, it is the standard of care to indicate prostate cancer diagnosis that may lead to further testing or a prostate biopsy. Making the biopsy decision is an important consideration between you and your doctor because there are sometimes physical complications. The ExoDx Prostate test will provide your doctor with important information to help you make this decision.
Move forward with confidence as interpreting the score is easy. The ExoDx Prostate test score ranges from 0–100. If your score is above 15.6, there is a higher risk for clinically significant prostate cancer that needs further investigation, such as a prostate biopsy. Talk to your doctor about this procedure.
We're here to help.
Learn MoreLearn more about the ExoDx Prostate test and At-Home Collection Kit options.
Call your ExoCARES Representative at 844-396-7663, select option 3, then option 2.
Billing Information
Thank you for choosing Exosome Diagnostics to perform your prostate cancer risk assessment. Through our laboratory services, we seek to empower patients with information to help them make informed decisions about their care. Similarly, we want to empower patients with information related to the costs of the test and our billing policy so that you can minimize concerns regarding payment. We are here for you at every stage of the billing process.
Frequently Asked Questions
Is the EPI Test covered by health insurance?
Most claims are covered by insurance companies and we continue to add coverage from additional insurance plans. However, only your insurance company can determine if the cost of the test is a covered benefit. The code to use is CPT PLA 0005U.
If I have health insurance, will I have any out-of-pocket expense?
Given the differences among health insurance programs that determine covered services, co-insurance, co-pay and deductibles, it is difficult for Exosome Diagnostics to determine what any one individual’s out-of-pocket cost for the test might be at any given time in the year.
If I have gone through the appeals process, but am still unable to pay, what are my options?
Please review the information on our Patient Assistance Program (PAP) to determine whether you qualify for a reduced out-of-pocket cost for The EPI Test. In addition, several payment plan options are available. Please contact our billing department at 844-EXOSOME (844-396-7663), Option 3, for more information.
What is the cost of the test?
The cost of the test depends on your individual health insurance coverage (for example, in-network, out-of-network, co-insurance, deductible and co-pay)
Do you have a flexible payment plan?
Yes, we offer an interest-free payment plan over a period of up to 6 months.
How do I make a payment?
Please call our billing department at 844-EXOSOME, Option 3, to arrange for payments. Screening tests are eligible for reimbursement with a flexible spending account (FSA), a health savings account (HSA), a health reimbursement arrangement (HRA), or a limited care flexible spending account (LCFSA).
We accept all major credit cards, checks and money orders
We now accept online payment for patient invoices after 7/01/2020
What if my insurance plan sends me a check directly for The EPI Test?
- Endorse the check by signing the back and writing the following under your signature: "Payable to Exosome Diagnostics, Inc."
- Please mail the check along with any cost-sharing, deductible or co-pay amounts and a copy of the Explanation of Benefits (EOB) to the following address:
Exosome Diagnostics Billing
PO Box 83405
Woburn, MA 01813-3405